Progenics Pharma (PGNX) – Hot Corp. News
-
Progenics Pharma (PGNX) Phase 3 CONDOR Trial of PyL in Prostate Cancer Achieved Primary Endpoint
-
Lantheus (LNTH) to Acquire Progenics (PGNX) in All-Stock Transaction
-
-
-
-
-
-
-
-
-
Back to PGNX Stock Lookup